Crossmark

Recombinant Expression of a New Antimicrobial Peptide Composed of hBD-3 and hBD-4 in Escherichia coli and Investigation of Its Activity Against Multidrug-Resistant Bacteria

Crossref DOI link: https://doi.org/10.1007/s12602-025-10456-y

Published Online: 2025-01-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ning, Nianzhi

Yan, Han

Cao, Binwang

Yu, Wenjing

Zhang, Liangyan

Li, Deyu

Li, Tao

Zhang, Xingxiao

Wang, Hui
Funding

Funding for this research was provided by:

Funded by the State Key Laboratory of Pathogen and Biosecurity (SKLPBS2228)
License Information

Text and Data Mining valid from 2025-01-18

Version of Record valid from 2025-01-18
More Information

Article History

Accepted: 7 January 2025

First Online: 18 January 2025

Declarations

:

: Not required.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below